By naturally enhancing GLP-1 activity, Saba GLP-1 may help reduce unnecessary snacking, support portion control, and encourage healthier daily habits
CagriSema (semaglutide + cagrilintide), filed by Novo Nordisk in December 2025, achieved 22.7% weight loss in trials and could receive FDA approval in 2026
Birth control is probably a little bit more likely [to fail], if you're on something that decreases absorption, says Christina Boots, a reproductive endocrinologist and infertility specialist at Northwestern University in Chicago, Illinois
Glowing Skin makes dull skin look bright and fresh
Tirzepatide expanded that conversation by targeting two hormone pathways instead of one
I snacked less between meals, portioned out more mindful serving sizes, and avoided alcoholthe naltrexone part of the medication I was taking, which is used for alcohol dependency management, unsurprisingly converts two glasses of wine into a beastly multi-day hangover, so liquid calories were out of the question